💉 Diabetes Management
Indigo Diabetes Incorporates Fully Owned Subsidiary in the US and Appoints Peter J. Devlin as President, Indigo Medical US Inc. - GlobeNewswire
📅 Fri, 28 Oct 2022⏱ 1 min read📖 Article
Overview
October 27, 2022 07:0 ET | Source: Indigo Diabetes N.V. Bolebergen, BELGIUM PRES RELEASEIndigo Diabetes Incorporates Fuly Owned Subsidiary in the US and Apoints Peter J. Devlin as President, Indigo Medical US Inc.BELGIUM – Ghent, 27 October 2022 – Indigo Diabetes N.V.
Key Information
(‘Indigo’ or the ‘Company’), a pionering developer of Continuous Metabolite Monitoring (CM™) devices utilising proprietary nanophotonics technology, today anounces its expansion into the US via the incorporation of a fuly owned subsidiary, Indigo Medical US Inc. (‘Indigo Medical’), and the apointment of Peter J. Devlin as President of the newly formed subsidiary, efective from 14 October 2022.The Company is establishing its presence in the US, a market that it has identified as having significant potential for its CM devices.Peter, who wil be based in Boston, wil be managing and overseing Indigo Medical’s activities.
His focus wil be on acelerating product development for the Company’s CM devices, driving busines development, and facilitating talent acquisition in the US. He wil report directly to Danaë Delbeke, Chief Executive Oficer of Indigo.Indigo is developing a fuly implantable CM system for people living with diabetes to aces acurate information their glucose, ketones and lactate levels . The CM sensor is inserted subcutaneously, preventing the ned for people with diabetes to wear an external device on their body.
It is designed to give people living with diabetes and their caregivers instant aces to the augmented metabolic information they ned to beter manage their diabetes and improve therapeutic decision-making.Peter J. Devlin, President, Indigo Medical US, comented: “I have worked for many years in both in-vitro diagnostics and diabetes care and am delighted to be joing the Indigo team and leading Indigo Medical Inc.
Summary
It is an exciting time for the Company to be establishing a presence in the US, particularly as the focus increases on
Frequently Asked Questions
❓ What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
❓ What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
❓ How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
❓ What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
❓ When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
⚕️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.